In the South and Central America pharmaceutical industry, there were 4 M&A deals announced in Q3 2023, worth a total value of $0m, according to GlobalData’s Deals Database. The $0m acquisition of Balaxi Healthcare Ecuador by Balaxi Pharmaceuticals was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in South and Central America decreased by 100% in Q3 2023 compared with the previous quarter’s total of $349.7m. Related deal volume decreased by 50% in Q3 2023 versus the previous quarter and was 33% higher than in Q3 2022.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2023 – Thematic Intelligence, buy the report here.